Synapse - Andrew Zelenetz

Results (785)

Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience

Meeting Abstract

Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma

Journal Article

Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
Biology of Blood and Marrow Transplantation (2014)

Fulltext@MSK | Save

Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial

Meeting Abstract

Stilgenbauer, S.; Hallek, M. J.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
Oncology Research and Treatment (2014)

Fulltext@MSK | Save

Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial

Meeting Abstract

Stilgenbauer, S.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
Haematologica (2014)

Fulltext@MSK | Save

Pre-treatment with idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL

Meeting Abstract

Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; more...
Haematologica (2014)

Fulltext@MSK | Save

Pre-treatment with Idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL

Meeting Abstract

Hallek, M.; Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
Oncology Research and Treatment (2014)

Fulltext@MSK | Save

2nd analysis of a phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Idelalisib and Rituximab for previously treated patients with chronic lymphocytic leukemia

Meeting Abstract

Hallek, M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
Oncology Research and Treatment (2014)

Fulltext@MSK | Save

Effect of idelalisib/rituximab combination treatment of relapsed cll on the bcr signaling-related chemokines ccl3 and ccl4: Data from a phase 3, randomized, double-blind, placebo-controlled trial